BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 11724443)

  • 1. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis.
    Egg R; Reindl M; Deisenhammer F; Linington C; Berger T
    Mult Scler; 2001 Oct; 7(5):285-9. PubMed ID: 11724443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimyelin antibodies and the risk of relapse in patients with a primary demyelinating event.
    Rauer S; Euler B; Reindl M; Berger T
    J Neurol Neurosurg Psychiatry; 2006 Jun; 77(6):739-42. PubMed ID: 16705196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels of anti-myelin antibodies in relapsing-remitting multiple sclerosis patients during different phases of disease activity and immunomodulatory therapy.
    Angelucci F; Mirabella M; Frisullo G; Caggiula M; Tonali PA; Batocchi AP
    Dis Markers; 2005; 21(2):49-55. PubMed ID: 15920290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant forms of myelin antigens expressed on Chinese hamster ovary (CHO) cells as a tool for identification of autoantibodies in serum of multiple sclerosis patients.
    Jaśkiewicz E; Michałowska-Wender G; Pyszczek A; Wender M
    Folia Neuropathol; 2010; 48(1):45-8. PubMed ID: 20383810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between antimyelin antibodies and progression to multiple sclerosis.
    Kuhle J; Pohl C; Mehling M; Edan G; Freedman MS; Hartung HP; Polman CH; Miller DH; Montalban X; Barkhof F; Bauer L; Dahms S; Lindberg R; Kappos L; Sandbrink R
    N Engl J Med; 2007 Jan; 356(4):371-8. PubMed ID: 17251533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS.
    Tomassini V; De Giglio L; Reindl M; Russo P; Pestalozza I; Pantano P; Berger T; Pozzilli C
    Mult Scler; 2007 Nov; 13(9):1086-94. PubMed ID: 17468447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association.
    Mantegazza R; Cristaldini P; Bernasconi P; Baggi F; Pedotti R; Piccini I; Mascoli N; La Mantia L; Antozzi C; Simoncini O; Cornelio F; Milanese C
    Int Immunol; 2004 Apr; 16(4):559-65. PubMed ID: 15039386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to myelin oligodendrocyte glycoprotein and myelin basic protein depend on familial background and are partially associated with human leukocyte antigen alleles in multiplex families and sporadic multiple sclerosis.
    Lutterotti A; Reindl M; Gassner C; Poustka K; Schanda K; Deisenhammer F; Berger T
    J Neuroimmunol; 2002 Oct; 131(1-2):201-7. PubMed ID: 12458053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies against glycosylated native MOG are elevated in patients with multiple sclerosis.
    Gaertner S; de Graaf KL; Greve B; Weissert R
    Neurology; 2004 Dec; 63(12):2381-3. PubMed ID: 15623705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
    Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
    J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF.
    Kuhle J; Lindberg RL; Regeniter A; Mehling M; Hoffmann F; Reindl M; Berger T; Radue EW; Leppert D; Kappos L
    J Neurol; 2007 Feb; 254(2):160-8. PubMed ID: 17334662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demyelinating antibodies to myelin oligodendrocyte glycoprotein and galactocerebroside induce degradation of myelin basic protein in isolated human myelin.
    Menon KK; Piddlesden SJ; Bernard CC
    J Neurochem; 1997 Jul; 69(1):214-22. PubMed ID: 9202313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord blood contains cells secreting antibodies to nervous system components.
    Fredrikson S; Sun J; Xiao BG; Link H
    Clin Exp Immunol; 1991 May; 84(2):353-8. PubMed ID: 1709072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral response against glial derived antigens in Parkinson's disease.
    Papuć E; Kurzepa J; Kurys-Denis E; Grabarska A; Krupski W; Rejdak K
    Neurosci Lett; 2014 Apr; 566():77-81. PubMed ID: 24594199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
    Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
    Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis.
    Zhou D; Srivastava R; Nessler S; Grummel V; Sommer N; Brück W; Hartung HP; Stadelmann C; Hemmer B
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19057-62. PubMed ID: 17142321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.
    Lalive PH; Menge T; Delarasse C; Della Gaspera B; Pham-Dinh D; Villoslada P; von Büdingen HC; Genain CP
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2280-5. PubMed ID: 16461459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to myelin basic protein, myelin oligodendrocytes peptides, alpha-beta-crystallin, lymphocyte activation and cytokine production in patients with multiple sclerosis.
    Vojdani A; Vojdani E; Cooper E
    J Intern Med; 2003 Oct; 254(4):363-74. PubMed ID: 12974875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity to myelin antigens in multiple sclerosis. Peripheral blood lymphocytes respond predominantly to myelin oligodendrocyte glycoprotein.
    Kerlero de Rosbo N; Milo R; Lees MB; Burger D; Bernard CC; Ben-Nun A
    J Clin Invest; 1993 Dec; 92(6):2602-8. PubMed ID: 7504688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.